| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/08/2007 | WO2007015783A2 Attenuated strains of flaviviruses , and uses thereof |
| 02/08/2007 | WO2007015782A1 Molecular variant fibrinogen fusion proteins |
| 02/08/2007 | WO2007015638A2 Methods and means for controlling the endocytosis and subsequent degradation of a cell surface protein |
| 02/08/2007 | WO2007015540A1 Cytotoxic t-cell epitope peptide and use thereof |
| 02/08/2007 | WO2007014824A1 Fat taste receptors and their methods of use |
| 02/08/2007 | WO2007014744A2 C-terminal tnf-family ligand (ctl) -prodrug |
| 02/08/2007 | WO2007014743A2 Cd33-specific single-chain immunotoxin and method of use |
| 02/08/2007 | WO2007014463A1 Nalp7-based diagnosis of female reproductive conditions |
| 02/08/2007 | WO2007014415A1 Helminth antigen and immunotherapy |
| 02/08/2007 | WO2006138700A3 Anchored transferrin fusion protein libraries |
| 02/08/2007 | WO2006133182A3 Insect-specific protease recognition sequences |
| 02/08/2007 | WO2006126595A9 Three-dimensional structure of functional material |
| 02/08/2007 | WO2006077442A3 Inhibition of islet amyloid polypeptide (iapp) aggregation for the treatment of type 2 diabetes |
| 02/08/2007 | WO2006067506A3 Hiv resistance genes |
| 02/08/2007 | WO2006060484A3 Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
| 02/08/2007 | WO2005122379A3 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 02/08/2007 | WO2005044987A3 Tocopherol associated protein and uses thereof |
| 02/08/2007 | WO2005032453A3 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 02/08/2007 | WO2005001049A3 Compositions, splice variants and methods relating to ovarian specific genes and proteins |
| 02/08/2007 | WO2004072260A3 Cell free assay systems for identifying a substance of interest |
| 02/08/2007 | WO2004044124A3 Identification of oligoadenylate synthetase-like genes |
| 02/08/2007 | WO2003068934A3 Chimeric molecules for cleavage in a treated host |
| 02/08/2007 | US20070033676 glucagon-like peptide-1 (GLP-1) which is peptidase-resistant; has resistance to trypsin; producing a plant storage organ in which the recombinant protein is highly produced |
| 02/08/2007 | US20070033671 Polynucleotides and polypeptides in plants |
| 02/08/2007 | US20070033669 Semaphorin gene family |
| 02/08/2007 | US20070033668 Inbred miniature swine and uses thereof |
| 02/08/2007 | US20070033662 GLP-2 receptor gene promoter and uses thereof |
| 02/08/2007 | US20070032961 Apparatus and method for automated protein design |
| 02/08/2007 | US20070032643 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same |
| 02/08/2007 | US20070032642 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032639 Identification of new small RNAs and ORFs of E. coli as mediators of cell and intercell regulation |
| 02/08/2007 | US20070032638 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain |
| 02/08/2007 | US20070032637 a crystal complex of an epidermal growth factor (EGF) and an epidermal growth factor receptor (EGFR), used for screening and for designing the substance that regulate EGFR activity |
| 02/08/2007 | US20070032636 Chimeric retroviral Gag genes and screening assays |
| 02/08/2007 | US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 02/08/2007 | US20070032446 Gapped 2' modified oligonucleotides |
| 02/08/2007 | US20070032439 Tarp promoter and uses thereof |
| 02/08/2007 | US20070032428 Novel antimicrobial agents |
| 02/08/2007 | US20070032419 Fusion polypeptide, which comprise a peptide of 3-30 amino acids, which permits the fusion polypeptide to be bound selectively to tumor vessel endothelial cells, and the tissue factor or a fragment thereof; enables the fusion polypeptide to be bound selectively to tumor vessel endothelial cells |
| 02/08/2007 | US20070032417 Peptides and therapeutic uses thereof |
| 02/08/2007 | US20070032416 Chorionic somatomammotropin hormone splice variants |
| 02/08/2007 | US20070032415 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 02/08/2007 | US20070032412 Particularly Kahalalide F, a tridecapeptide with a ring shape side and a lateral side amidated with 5-methylhexanoic acid; 650 mu g/m2/day administered intravenously in cycles of 1-4 weeks |
| 02/08/2007 | US20070032411 Protein kinase signalling |
| 02/08/2007 | US20070032408 Novel spacer moiety for poly (ethylene glycol) modified peptide based compounds |
| 02/08/2007 | US20070032406 Identification of novel nogo-receptors and methods related thereto |
| 02/08/2007 | US20070031979 Protein biopolymer markers predictive of type II diabetes |
| 02/08/2007 | US20070031973 Triazine derivatives as universal peptide isotope tag reagents (U-PIT) |
| 02/08/2007 | US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 02/08/2007 | US20070031946 Arginine repressor deficient strain of coryneform bacterium and method for producing L-arginine |
| 02/08/2007 | US20070031938 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof |
| 02/08/2007 | US20070031937 Co-expression of recombinant proteins |
| 02/08/2007 | US20070031936 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/08/2007 | US20070031935 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/08/2007 | US20070031934 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/08/2007 | US20070031933 Determining whether a DNA sequence comprises a gene transcription modulating quality and/or a gene transcription repressing quality; systematic elucidation and identification of regulatory sequences |
| 02/08/2007 | US20070031931 Biosynthetic binding proteins for immuno-targeting |
| 02/08/2007 | US20070031930 Includes lowering the pH of a whole E coli cell solution to form an acidic solution, disrupting the cells to release the protein into the acidic solution, and separating the cellular debris from the released protein to obtain a protein product enriched in the heterologous target protein |
| 02/08/2007 | US20070031929 Polypeptides Homologous To VEGF and BMP1 |
| 02/08/2007 | US20070031926 Refolded membrane protein in monodisperse form |
| 02/08/2007 | US20070031925 Small molecular weight TNF receptor multimeric molecule |
| 02/08/2007 | US20070031924 recombinant polynucleotide that encodes a cell surface polypeptide comprising a biomolecule partition motif that can direct targeting of intracellular polypeptides to and through membranes, including cell surface membranes |
| 02/08/2007 | US20070031922 Nucleotide sequences coding chimeric immunoglobulin comprising salavage receptor binding epitope for use as reporter in immunodiagnostic and immunotherapeutics |
| 02/08/2007 | US20070031921 Potent combinations of mrna transport elements |
| 02/08/2007 | US20070031920 High expression locus vector based on ferritin heavy chain gene locus |
| 02/08/2007 | US20070031908 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection reagents |
| 02/08/2007 | US20070031904 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031903 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031899 Using serine/threonine kinase Pim-1 polypeptide phosphorylation inhibition after exposure to modulator as indication of antitumor/cancer activity; treating pancreatic cancer |
| 02/08/2007 | US20070031897 Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRP |
| 02/08/2007 | US20070031894 Novel nerve stem cell marker |
| 02/08/2007 | US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/08/2007 | US20070031878 Methods and compositions for polypeptide engineering |
| 02/08/2007 | US20070031872 A141S and G399S mutation in the Omi/HtrA2 protein in Parkinson's disease |
| 02/08/2007 | US20070031864 Polyvalent cation-sensing receptor in atlantic salmon |
| 02/08/2007 | US20070031860 G-protein coupled receptor and uses therefor |
| 02/08/2007 | US20070031855 Receptor for a bacillus thuringiensis toxin |
| 02/08/2007 | US20070031854 Novel 10,10'-substituted-9,9'-biacridilidine luminescent molecules their preparation and uses |
| 02/08/2007 | US20070031852 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 02/08/2007 | US20070031851 An array of probes comprises the open reading frames of a nucleotide sequence, on solid supports, used for detecting gene expression, monitoring the cell cycle of eukaryotic cells and for screening antifungal agents |
| 02/08/2007 | US20070031842 379 human secreted proteins |
| 02/08/2007 | US20070031836 Altered Bacillus SecA comprising at least one amino acid change in IRA-1 and/or IRA-2 (intramolecular regulator of ATP hydrolysis) |
| 02/08/2007 | US20070031832 production and of nucleic acid fragment libraries that express highly diverse peptides, polypeptides or protein domains and, in particular, nucleic acid fragment libraries wherein the nucleic acid fragments are derived from two or more prokaryote genomes or compact eukaryote genomes |
| 02/08/2007 | US20070031511 Method of treatment |
| 02/08/2007 | US20070031506 Interleukin-18 inducer |
| 02/08/2007 | US20070031501 Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions |
| 02/08/2007 | US20070031478 Modified peptides and their uses |
| 02/08/2007 | US20070031458 Recombinant Vibrio cholerae strain and vaccine comprising said strain |
| 02/08/2007 | US20070031453 Modified influenza virus for monitoring and improving vaccine efficiency |
| 02/08/2007 | US20070031452 rheumatoid arthritis; nervous system disorders; endogenous retroviral elements (ERV) |
| 02/08/2007 | US20070031449 A Neisserial bacterium in which the expression of an Imp protein is functionally downregulated so that the level of lipopolysaccharide in the outer membrane is decreased compared to the wild-type; outer membrane vesicle preparations used as vaccines |
| 02/08/2007 | US20070031447 Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides |
| 02/08/2007 | US20070031446 Hcv vaccines |
| 02/08/2007 | US20070031445 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 02/08/2007 | US20070031444 Compounds targeted to cellular locations |
| 02/08/2007 | US20070031443 Methods for treating or preventing skin disorders using CD2-binding agents |
| 02/08/2007 | US20070031442 Method and compositions for boosting immune response |
| 02/08/2007 | US20070031439 Novel protein related to melanoma-inhibiting protein and uses thereof |
| 02/08/2007 | US20070031436 Bivalent monomeric Fv antibody formed by one single-chain Fv monomer having four variable domains; expression plasmids which code for an Fv antibody; diagnosis; stability; no undesired immune response; side effect reduction; lack constant domains |